Nanotechnology-based mRNA vaccines: From the fight against COVID-19 to cancer immunotherapy and HIV vaccines

The success of mRNA technology in the development of a COVID-19 vaccine has become a groundbreaking development in the fight against cancer, as well as in the development of new vaccines against many other infectious diseases, including HIV. Future nanotechnology-based mRNA vaccines could allow the delivery of multiple antigen-targeted vaccines in one vaccine lipid nanoparticle to protect against multiple diseases, thereby reducing the number of vaccines needed to prevent common vaccine-preventable diseases.